ALZHEIMER'S DRUG DISCOVERY FOUNDATION (EIN 201082179) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Principal Officer

HOWARD FILLIT MD

Phone

2129018000

Tax Period

2023-01-01 to 2023-12-31

ALZHEIMER'S DRUG DISCOVERY FOUNDATION, founded in 2004, is a mid-sized nonprofit in the Social Science sector that reported $37.7M in total revenue in fiscal year 2023. Revenue fell 85% from the prior year — a significant decline worth monitoring. Expenses of $61.9M exceeded revenue, resulting in a 64% operating deficit.

Mission

ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT AND TREAT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $30,595,495

Program Service Revenue $4,205,157

Investment Income $3,119,933

Other Revenue $-178,565

TOTAL REVENUE $37,742,020

Expense Breakdown

Grants Paid $47,673,524

Salaries & Benefits $8,326,107

Fundraising Expenses $4,049,179

Program Expenses $55,585,427

Other Expenses $5,943,957

TOTAL EXPENSES $61,943,588

Year-over-Year Comparison

	2023	2022	Change
Revenue	$37,742,020	$254,027,105	-0.9%
Expenses	$61,943,588	$36,842,901	+0.7%
Net Income	$-24,201,568	$217,184,204	-1.1%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,715,374

Total Directors

$664,906

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ALICE SHURE	GOVERNOR	1.00	Director	$0	$0	$0
BEATRIZ ILLESCAS PUTZEYS-CLAUGUS	GOVERNOR	1.00	Director	$0	$0	$0
BONNIE PFEIFER EVANS	GOVERNOR	1.00	Director	$0	$0	$0
DAVID WEINREB	GOVERNOR	1.00	Director	$0	$0	$0
GARY M LAUDER	GOVERNOR	1.00	Director	$0	$0	$0
HOWARD FILLIT MD	FOUNDING EXEC. DIR. & CHIEF SCI. OFF.	40.00	Officer Director	$632,502	$32,404	$664,906
LANNY EDELSOHN MD	GOVERNOR	1.00	Director	$0	$0	$0
LAURENCE LEEDS JR	GOVERNOR	1.00	Director	$0	$0	$0
LEONARD LAUDER	CO-CHAIRMAN /GOVERNOR	1.00	Officer Director	$0	$0	$0
MELVIN GOODES	HONORARY GOVERNOR	1.00	Director	$0	$0	$0
MIIA KIVIPELTO MD PHD	GOVERNOR	1.00	Director	$0	$0	$0
NANCY CORZINE	GOVERNOR	1.00	Director	$0	$0	$0
NANCY GOODES	GOVERNOR	1.00	Director	$0	$0	$0
PAULA ZAHN	GOVERNOR	1.00	Director	$0	$0	$0
RANDAL SANDLER	CO-VICE CHAIRMAN & SECRETARY	1.00	Officer Director	$0	$0	$0
RICHARD MOHS PHD	GOVERNOR	1.00	Director	$0	$0	$0
ROBERT BELFER	GOVERNOR	1.00	Director	$0	$0	$0
ROBERTA DIAZ BRINTON PHD	GOVERNOR	1.00	Director	$0	$0	$0
RONALD LAUDER	CO-CHAIRMAN /GOVERNOR	1.00	Officer Director	$0	$0	$0
SANDRA DAY O'CONNOR	HONORARY CHAIRMAN	1.00	Director	$0	$0	$0
SHARON SAGER	GOVERNOR	1.00	Director	$0	$0	$0
THOMAS MCWILLIAMS	CO-VICE CHAIRMAN & TREASUR	1.00	Officer Director	$0	$0	$0
THOMAS SMITH JR	GOVERNOR	1.00	Director	$0	$0	$0
KAREN HARRIS	CFO AND HEAD OF MISSION	40.00	Officer	$366,749	$24,726	$391,475
MARK ROITHMAYR	CEO	40.00	Officer	$619,606	$39,387	$658,993
AARON BURSTEIN	HEAD OF SEARCH AND EVALUATION	40.00	Highest	$301,736	$48,360	$350,096
CHRISTOPHER CARLSON	DIRECTOR, SEARCH & EVALUATION	40.00	Highest	$182,770	$30,842	$213,612
JANE MCINTOSH	CHIEF EXTERNAL AFFAIRS	40.00	Highest	$359,470	$12,350	$371,820
LAKITA CAVIN	ATTORNEY, MISSION-RELATED INVESTMENTS	40.00	Highest	$208,205	$21,418	$229,623
LAURA NISENBAUM	EXECUTIVE DIRECTOR, DRUG DEV.	40.00	Highest	$434,157	$32,393	$466,550

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$37,742,020	$61,943,588	$324,173,528	$-24,201,568
2022	$254,027,105	$36,842,901	$340,253,841	$217,184,204
2021	$53,037,104	$37,126,176	$116,420,075	$15,910,928
2020	$27,631,350	$28,251,909	$97,381,722	$-620,559
2019	$22,712,391	$32,429,304	$97,175,562	$-9,716,913
2018	$55,817,240	$16,190,686	$90,038,223	$39,626,554

ALZHEIMER'S DRUG DISCOVERY FOUNDATION